Medical/Pharmaceuticals
Senhwa Announces IND Submission to India's CDSCO of a Phase II Clinical Study for Silmitasertib as a Potential COVID-19 Treatment
TAIPEI and SAN DIEGO, June 23, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on developing first-in-class therapeutics for the treatment of cancer, rare conditions, and novel coronaviruses, today announced that it has submitted an I...
2021-06-23 19:00
1780
Biocytogen Completes a New Round of Financing Totaling Tens of Millions of Dollars
BEIJING, June 23, 2021 /PRNewswire/ -- Biocytogen
2021-06-23 17:02
2909
Envirotainer Welcomes Qatar Airways Cargo as the latest airline to approve the new Releye® RLP
STOCKHOLM, June 23, 2021 /PRNewswire/ -- Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that Qatar Airways Cargo has approved the Envirotainer Releye® RLP container for their fleet of aircraft. With this approval, t...
2021-06-23 16:55
1822
Clinical Application of Lunit AI For Chest Radiography and Mammography to Be Presented at AOCR 2021
* Two South Korean radiologists share benefits and feedback of using AI products for chest x-rays and mammograms in an actual patient care * Company expects to deliver the diagnostic value of AI and expand its implementation across clinical sites in theAsia-Pacific region SEOUL, June 23, 2021...
2021-06-23 10:28
3283
Sintilimab in Combination with Chemotherapy Meets Overall Survival Primary Endpoint in the Global Phase 3 ORIENT-15 Study for the First-Line Treatment of Esophageal Squamous Cell Carcinoma
SAN FRANCISCO and SUZHOU, China, June 23, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
2021-06-23 09:16
21012
Biocytogen Completes a New Round of Financing Totaling Tens of Millions of Dollars
BEIJING and BOSTON, June 22, 2021 /PRNewswire/ -- Biocytogen, an international biotechnology company focused on antibody drug research and development (R&D) using innovative genetically engineered animal models, today announced the successful completion of a new round of financing totaling tens o...
2021-06-23 04:16
1892
Mina J. Bissell Ph.D. & Vectorspace AI Advance New Space Biosciences Division
SAN FRANCISCO, June 23, 2021 /PRNewswire/ -- As the new space race heats up, more humans will be traveling into space than ever before. Spaceflight causes many changes in human health. Humans cannot be sent into space without understanding how to protect and repair human DNA along with tissue re...
2021-06-23 03:16
1850
Global Water Scarcity and Hospitalization Rates Stimulate the Polymeric Membranes Market
The demand for water treatment membranes and medical membranes will drive the global market, says Frost & Sullivan SANTA CLARA, Calif., June 23, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis of the global polymeric membranes market finds that the drive to achieve a circular economy and...
2021-06-23 00:14
2321
Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia
SHENZHEN, China, June 22, 2021 /PRNewswire/ -- On June 21, local time, phase III clinical fieldwork of the Inactivated COVID-19 Vaccine (Vero cells) independently developed and manufactured by Shenzhen Kangtai Biological Products Co., Ltd. was officially initiated inMalaysia, and the first batch ...
2021-06-22 22:32
9843
Insilico Medicine Raises $255 Million in Series C Financing Led by Warburg Pincus
NEW YORK and HONG KONG, June 22, 2021 /PRNewswire/ -- Insilico Medicine, a global leader in end-to-end artificial intelligence for target discovery, small molecule chemistry, and clinical development, announced that it has closed a $255 million Series C financing led by Warburg Pincus. The financi...
2021-06-22 21:46
4332
Eurofins Discovery and ImmunoPrecise Announce Collaboration to Expand their Antibody Discovery Platform
ST. CHARLES, Mo., June 22, 2021 /PRNewswire/ -- Eurofins Discovery, the leading provider of products and services to the drug discovery industry and a Eurofins Scientific (EUFI.PA) company, and ImmunoPrecise Antibodies (Nasdaq:IPA), the market leader in full-service therapeutic discovery and deve...
2021-06-22 20:28
5599
Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2021 Financial Results
HONG KONG, June 22, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financial ...
2021-06-22 19:00
24846
Alfasigma acquires the European license for bentracimab from PhaseBio
BOLOGNA, Italy, 22 giugno 2021 /PRNewswire/ -- Alfasigma has entered into an exclusive licensing agreement with PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), for the commercialization of bentracimab in 49 countries acrossEurope and other key markets. PhaseBio is a biopharmaceutical company focu...
2021-06-22 14:45
2964
Asieris Announces First Patient Treated in Europe in APRICITY, the Multinational Phase III Clinical Trial of APL-1702, Cevira®
SHANGHAI, June 22, 2021 /PRNewswire/ -- Asieris Pharmaceuticals (Asieris) today announced dosing of the first patient inEurope in its multinational, multicenter, Phase III clinical trial (APRICITY) of its photodynamic drug-device combination product APL-1702, Cevira® which is being developed for ...
2021-06-22 13:15
1585
INDICAID(R) COVID-19 Rapid Antigen Test certified by Cambodia's Ministry of Health for Disease Control
HONG KONG and PHNOM PENH, Cambodia, June 22, 2021 /PRNewswire/ -- Cambodia's Ministry of Health has approved INDICAID® COVID-19 Rapid Antigen Test for commercialisation as part of the country's efforts in controlling recent spikes of COVID-19 cases in the region. Rapid antigen tests like INDIC...
2021-06-22 09:00
4535
Innovent Announces the Approval of Pemazyre® (pemigatinib) in Taiwan Market for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement
SAN FRANCISCO and SUZHOU, China, June 22, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-06-22 08:00
20369
New Patient Guide from NCCN Jumpstarts Important Conversations About Anal Cancer
New and updated patient and caregiver resources from National Comprehensive Cancer Network offer jargon-free, state-of-the-art information on diagnosis, treatment, and surveillance for anal, colon, and rectal cancers. PLYMOUTH MEETING, Pa., June 21, 2021 /PRNewswire/ -- The National Comprehensiv...
2021-06-21 23:36
1901
2021 ASCO - AnchorDx Unveils Robust Validation Result of Multi-cancer Screening Technology AURORA
GUANGZHOU, China, June 21, 2021 /PRNewswire/ -- At this year's American Society of Clinical Oncology (ASCO) Annual Meeting 2021 (June 4-8), AnchorDx, a world-leading developer of cancer screening and early detection solutions, unveiled further validation results on the generalization performance ...
2021-06-21 23:19
621
Berry Oncology Partners with Alibaba Health to Create China's Early Cancer Screening Ecosystem
BEIJING, June 21, 2021 /PRNewswire/ -- Berry Oncology Corporation, a member company of Berry Genomics, and Alibaba Health have signed a strategic agreement to jointly build a comprehensive cancer screening and prevention ecosystem based on a strategy that combines internet connectivity, early can...
2021-06-21 21:00
1892
The Pressing Need for Early Detection of Mucormycosis during COVID-19
DONGGUAN, China, June 21, 2021 /PRNewswire/ -- Mucormycosis or black fungus, a
devastating infection that soars inIndia during COVID-19 has seized global
attention. Recently, the country's mucormycosis cases reached over 57,150 and
resulted in54% mortality
2021-06-21 20:00
5277
Week's Top Stories
Most Reposted
Edufrienz 99: One of Asia's First Digital Platform Advancing Character Education for Future-Ready, Compassionate Children
[Picked up by 315 media titles]
2026-01-23 11:03
UOB prices AUD2 billion in five-year senior unsecured notes
[Picked up by 305 media titles]
2026-01-23 09:00AVPN's AI Opportunity Fund Expands Regional Efforts to Build AI Skilling Infrastructure for a Future-Ready Workforce Across Asia-Pacific
[Picked up by 302 media titles]
2026-01-21 12:39Government of Telangana and Blaize Sign MoU at Davos to Launch Telangana AI Innovation Hub and Advance Applied AI Initiatives
[Picked up by 297 media titles]
2026-01-22 15:16
Klook's study of 374,000 reviews finds that lesser-known cities create deeper emotional connection with travelers
[Picked up by 280 media titles]
2026-01-20 15:40
Most Read
Building the Run: Xtep Charts a New Community Ecosystem in Southeast Asia
2026-01-20 17:49
5428
